Inactivation of NFκB—which occurs in the tumor cell, as well as in the inflammatory cell—might be the reason why Curcumin, which is known to have only modest pharmacological effects, has these relatively strong chemopreventive properties, most likely synergistically interrupting the cross-stimulatory effect of cytokine production. The gene discussed is NFKB1; the disease is neoplasm.